Targeted drug therapy for various types of pulmonary hypertension
Target drugs for pulmonary arterial hypertension(PAH)have alleviated the clinical symptoms and improved exercise tolerance,accordingly significantly improved the prognosis of PAH patients since launched into the market.Presently most targeted drugs research focused on PAH.For pulmonary hypertension associated with lung diseases and/or hypoxia,and pulmonary hypertension associated with pulmonary artery obstructions,the clinical treatment evidence of PAH targeted drugs has increased in recent years.Based on this,this article reviewed the progress of PAH targeted drugs on different types of pulmonary hypertension,and provided reference for clinical rational drug use.
NETL
NSTL
万方数据
